Microrobots have the potential to revolutionize medicine. Researchers at the Max Planck ETH Centre for Learning Systems have now developed an imaging technique that for the first time recognises cell-sized microrobots individually and at high resolution in a living organism. | |
How can a blood clot be removed from the brain without any major surgical intervention? How can a drug be delivered precisely into a diseased organ that is difficult to reach? Those are just two examples of the countless innovations envisioned by the researchers in the field of medical microrobotics. | |
Tiny robots promise to fundamentally change future medical treatments: one day, they could move through patient’s vasculature to eliminate malignancies, fight infections or provide precise diagnostic information entirely noninvasively. In principle, so the researchers argue, the circulatory system might serve as an ideal delivery route for the microrobots, since it reaches all organs and tissues in the body. | |
For such microrobots to be able to perform the intended medical interventions safely and reliably, they must not be larger than a biological cell. In humans, a cell has an average diameter of 25 micrometres – a micrometre is one millionth of a metre. The smallest blood vessels in humans, the capillaries, are even thinner: their average diameter is only 8 micrometres. The microrobots must be correspondingly small if they are to pass through the smallest blood vessels unhindered. | |
However, such a small size also makes them invisible to the naked eye – and science too, has not yet found a technical solution to detect and track the micron-sized robots individually as they circulate in the body. | |
Tracking circulating microrobots for the first time |
|
“Before this future scenario becomes reality and microrobots are actually used in humans, the precise visualisation and tracking of these tiny machines is absolutely necessary,” says Paul Wrede, who is a doctoral fellow at the Max Planck ETH Center for Learnings Systems (CLS). | |
“Without imaging, microrobotics is essentially blind,” adds Daniel Razansky, Professor of Biomedical Imaging at ETH Zurich and the University of Zurich and a member of the CLS. “Real-time, high-resolution imaging is thus essential for detecting and controlling cell-sized microrobots in a living organism.” | |
Further, imaging is also a prerequisite for monitoring therapeutic interventions performed by the robots and verifying that they have carried out their task as intended. “The lack of ability to provide real-time feedback on the microrobots was therefore a major obstacle on the way to clinical application.” | |
Together with Metin Sitti, a world-leading microrobotics expert who is also a CLS member as Director at the Max Planck Institute for Intelligent Systems (MPI-IS) and ETH Professor of Physical Intelligence, and other researchers, the team has now achieved an important breakthrough in efficiently merging microrobotics and imaging. | |
In a study just published in the scientific journal Science Advances (“Real-time 3D optoacoustic tracking of cell-sized magnetic microrobots circulating in the mouse brain vasculature”), they managed for the first time to clearly detect and track tiny robots as small as five micrometres in real time in the brain vessels of mice using a non-invasive imaging technique. | |
The researchers used microrobots with sizes ranging from 5 to 20 micrometres. The tiniest robots are about the size of red blood cells, which are 7 to 8 micrometres in diameter. This size makes it possible for the intravenously injected microrobots to travel even through the thinnest microcapillaries in the mouse brain. |
The researchers also developed a dedicated optoacoustic tomography technology in order to actually detect the tiny robots one by one, in high resolution and in real time. This unique imaging method makes it possible to detect the tiny robots in deep and hard-to-reach regions of the body and brain, which would not have been possible with optical microscopy or any other imaging technique. | |
The method is called optoacoustic because light is first emitted and absorbed by the respective tissue. The absorption then produces tiny ultrasound waves that can be detected and analysed to result in high-resolution volumetric images. | |
Janus-faced robots with gold layer |
|
To make the microrobots highly visible in the images, the researchers needed a suitable contrast material. For their study, they therefore used spherical, silica particle-based microrobots with a so-called Janus-type coating. This type of robot has a very robust design and is very well qualified for complex medical tasks. It is named after the Roman god Janus, who had two faces. In the robots, the two halves of the sphere are coated differently. In the current study, the researchers coated one half of the robot with nickel and the other half with gold. |
“Gold is a very good contrast agent for optoacoustic imaging,” explains Razansky, “without the golden layer, the signal generated by the microrobots is just too weak to be detected.” | |
In addition to gold, the researchers also tested the use of small bubbles called nanoliposomes, which contained a fluorescent green dye that also served as a contrast agent. | |
“Liposomes also have the advantage that you can load them with potent drugs, which is important for future approaches to targeted drug delivery,” says Wrede, the first author of the study. The potential uses of liposomes will be investigated in a follow-up study. | |
Furthermore, the gold also allows to minimise the cytotoxic effect of the nickel coating – after all, if in the future microrobots are to operate in living animals or humans, they must be made biocompatible and non-toxic, which is part of an ongoing research. | |
In the present study, the researchers used nickel as a magnetic drive medium and a simple permanent magnet to pull the robots. In follow-up studies, they want to test the optoacoustic imaging with more complex manipulations using rotating magnetic fields. | |
“This would give us the ability to precisely control and move the microrobots even in strongly flowing blood,” says Metin Sitti. “In the present study we focused on visualising the microrobots. The project was tremendously successful thanks to the excellent collaborative environment at the CLS that allowed combining the expertise of the two research groups at MPI-IS in Stuttgart for the robotic part and ETH Zurich for the imaging part,” Sitti concludes. |

News
New Once-a-Week Shot Promises Life-Changing Relief for Parkinson’s Patients
A once-a-week shot from Australian scientists could spare people with Parkinson’s the grind of taking pills several times a day. The tiny, biodegradable gel sits under the skin and releases steady doses of two [...]
Weekly injectable drug offers hope for Parkinson’s patients
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the University of South Australia [...]
Most Plastic in the Ocean Is Invisible—And Deadly
Nanoplastics—particles smaller than a human hair—can pass through cell walls and enter the food web. New research suggest 27 million metric tons of nanoplastics are spread across just the top layer of the North [...]
Repurposed drugs could calm the immune system’s response to nanomedicine
An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, [...]
Nano-Enhanced Hydrogel Strategies for Cartilage Repair
A recent article in Engineering describes the development of a protein-based nanocomposite hydrogel designed to deliver two therapeutic agents—dexamethasone (Dex) and kartogenin (KGN)—to support cartilage repair. The hydrogel is engineered to modulate immune responses and promote [...]
New Cancer Drug Blocks Tumors Without Debilitating Side Effects
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI. A new cancer drug candidate, developed through a collaboration between Lawrence Livermore National Laboratory (LLNL), BridgeBio Oncology [...]
Scientists Are Pretty Close to Replicating the First Thing That Ever Lived
For 400 million years, a leading hypothesis claims, Earth was an “RNA World,” meaning that life must’ve first replicated from RNA before the arrival of proteins and DNA. Unfortunately, scientists have failed to find [...]
Why ‘Peniaphobia’ Is Exploding Among Young People (And Why We Should Be Concerned)
An insidious illness is taking hold among a growing proportion of young people. Little known to the general public, peniaphobia—the fear of becoming poor—is gaining ground among teens and young adults. Discover the causes [...]
Team finds flawed data in recent study relevant to coronavirus antiviral development
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-CoV-2's molecular structure known as the NiRAN domain—an [...]
Drug-Coated Neural Implants Reduce Immune Rejection
Summary: A new study shows that coating neural prosthetic implants with the anti-inflammatory drug dexamethasone helps reduce the body’s immune response and scar tissue formation. This strategy enhances the long-term performance and stability of electrodes [...]
Scientists discover cancer-fighting bacteria that ‘soak up’ forever chemicals in the body
A family of healthy bacteria may help 'soak up' toxic forever chemicals in the body, warding off their cancerous effects. Forever chemicals, also known as PFAS (per- and polyfluoroalkyl substances), are toxic chemicals that [...]
Johns Hopkins Researchers Uncover a New Way To Kill Cancer Cells
A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically unstable tumors. Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Radiation Oncology and Molecular [...]
AI matches doctors in mapping lung tumors for radiation therapy
In radiation therapy, precision can save lives. Oncologists must carefully map the size and location of a tumor before delivering high-dose radiation to destroy cancer cells while sparing healthy tissue. But this process, called [...]
Scientists Finally “See” Key Protein That Controls Inflammation
Researchers used advanced microscopy to uncover important protein structures. For the first time, two important protein structures in the human body are being visualized, thanks in part to cutting-edge technology at the University of [...]
AI tool detects 9 types of dementia from a single brain scan
Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single, widely available scan—a transformative [...]
Is plastic packaging putting more than just food on your plate?
New research reveals that common food packaging and utensils can shed microscopic plastics into our food, prompting urgent calls for stricter testing and updated regulations to protect public health. Beyond microplastics: The analysis intentionally [...]